Wednesday''s top analyst upgrades and downgrades included Alphabet, Danaher, Emerson Electric, Foot Locker, GoDaddy, Harley-Davidson, Meta Platforms, New York Community Bancorp, Nvidia, Prologis, Rio Tinto, Simon Property and Vornado Realty Trust.

Danaher Series B Preferred offers a compelling opportunity to capture a dividend payment of $12.5 per share payable on April 17. Click here for detailed analysis on DHR.PB.

Agilent and Danaher have significantly outperformed the market, and have solid competitive advantages. Find out which stock is better for long-term investors.

In December 2022, InvestorPlace.com contributor Joel Baglole picked out Seven Surprising Stock Picks for Contrarian-Minded Investors . His picks would prove masterful. Not only did he pick out Coinbase (NASDAQ: COIN ) – one of the top performers of the stock market this year. He also chose Meta Platforms (NASDAQ: META ), Zillow (NASDAQ: ZG ) and AMC Entertainment (NYSE: AMC ), a wide variety of 2023’s highest-returning stocks. Together, Joel’s seven picks have risen 37% since January. A stunning figure by any measure! I’m not cherry-picking results either. According to our internal reports, the analysts at InvestorPlace’s free market news and analysis website all tend to focus on high-performing stocks. Tesla (NASDAQ: TSLA ) is our most covered stock in 2023 so far (+67% YTD return). Microsoft (NASDAQ: MSFT ) (+8%), Alphabet (NASDAQ: GOOG ) (+6%) and Nvidia (NASDAQ: NVDA ) (+69%) round out our other most covered mega-cap picks. These are the companies InvestorPlace.com writers talk about the most.

The equities market continues to be incredibly volatile. Investors were optimistic following a robust rally in Jan.; all major U.S. indices are down since then. The ongoing churn is naturally vexing for investors but presents an excellent time for them to load up on the most undervalued stocks to buy. Wall Street is feeling the jitters of the upcoming jobs report which could result in more aggressive interest rate hikes. The Federal Reserve is committed to controlling inflation even if it triggers a recession to maintain price stability and protect the long-term health of the economy. Hence, investors are likely to face more curveballs ahead but the bear market has created multiple buying opportunities ahead that could pay many dividends down the road. I have compiled a list of some of the most undervalued stocks to buy at this time using GuruFocus’s market screener. Have a read through the list and consider these opportunities for investment. PFE Pfizer $39.39 DHR Danaher $239.75 CTSH Cognizant $60.38 TSLA Tesla $173.44 AMD Advanced Micro Devices $82.67 FANG Diamondback Energy $135.91 NOK Nokia $4.69 Most Undervalued Stocks: Pfizer ( PFE ) Source: Sisacorn / Shutterstock.com % Below 52-Week High: 29.9% Pfizer (NYSE: PFE ) was a top pandemic stock for obvious reasons.

Stimulus Matters to the Stock Market and to Danaher DHR

Danaher Corporation - Consensus Indicates Potential 19.4% Upside

Danaher has stellar high-moat M&A-driven business model with strong pricing power and often anti-cyclical customers. Check out what makes DHR stock a buy.

Danaher has benefited from the Covid-19 period and has seen strong (earnings) growth. Read more to see my recommendation on DHR stock.

In today’s recent session, 0.95 million shares of the Danaher Corporation (NYSE:DHR) have been traded, and its beta is 0.80. Most recently the company’s share price was $245.98, and it changed around -$1.97 or -0.79% from the last close, which brings the market valuation of the company to $183.11B. DHR at last check was trading … Danaher Corporation (NYSE: DHR)’s Stock Market Position Could Improve In The Coming Months Read More »

DUBLIN , Feb. 23, 2023 /PRNewswire/ -- The "Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Urine Tests, Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User, By Region" report has been added to ResearchAndMarkets.com''s offering. The global kidney function tests market was valued over USD 862 million in 2022 and is forecast to grow at a CAGR of 9.71% through 2028. Companies Mentioned Baxter International Inc Abbott Laboratories, Inc. Sysmex Corporation F. Hoffmann-La Roche Ltd Danaher Corporation URIT Medical Electronic Co. Ltd Nova Biomedical Corporation Laboratory Corporation of America Holdings Siemens Healthineers ARKRAY Inc. IDEXX Laboratories, Inc Fresenius SE & Co. KGaA Cook Group ACON Laboratories, Inc. Randox Laboratories Ltd. The growth of the global market for kidney function tests is anticipated to be supported by an increase in awareness of diagnostic techniques for kidney function.

Danaher (NYSE:DHR) declares $0.27/share quarterly dividend, 8% increase from prior dividend of $0.25.Forward yield 0.43%Payable April 28; for shareholders of record March 31; ex-div March…

WASHINGTON, Feb. 22, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 28, 2023 to holders of record on March 31, 2023. In addition, the…

Danaher Corporation - Consensus Indicates Potential 18.4% Upside

When many investors think about clean water stocks, the first thing that comes to mind for many investors is utility stocks . And hey, in today’s volatile market, the relative safety and security that comes from owning utilities is not a bad idea. But if you’re an investor looking for growth, you’ll be looking for more options. Right now, there are several interesting water stocks to consider. That’s because as you probably learned in school, only about 1% of the total water supply is drinkable. And some analysts predict that by 2025 as much as two-thirds of the world will face a shortage of freshwater. Many of us don’t think much about water. But several geographies of the world, including areas right here in the United States, are dealing with multi-year droughts. In parts of Arizona, California, and Nevada, water levels are at historic lows. Accordingly, the federal government is threatening to cut water use by 25%. In this article, I’ll highlight seven clean water stocks that are using clean water technology to address this ongoing crisis.

Related Stocks: V , ADP , CCI , QCOM , DHR ,

Related Stocks: JD , DHR , FLEX , STM , GOOGL ,

Related Stocks: DHR , NEE , DTP , FLOT , VXUS ,

Related Stocks: NEE , DHR , VWOB , IDEV , EMB ,

Danaher Corporation (NYSE:DHR) shares, rose in value on Friday, 02/10/23, with the stock price up by 1.46% to the previous day’s close as strong demand from buyers drove the stock to $258.84. Actively observing the price movement in the last trading, the stock closed the session at $255.11, falling within a range of $250.76 and … Danaher Corporation (NYSE: DHR) Stock Could Be An Option To Consider Read More »

Related Stocks: TSLA , AAPL , DHR , AMZN , ABMD ,

Related Stocks: DHR , DE , EW , TSM , BALL ,

WASHINGTON, Feb. 8, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") today announced that Veralto Corporation ("Veralto" or the "Company") will be the name of the separate public company Danaher intends to create in the fourth quarter of 2023. Veralto will be comprised of…

https://www.investing.com/news/pro/danahercatalent-speculation-could-lift-these-two-others-stocks--anayst-432SI-2997310

Related Stocks: ADBE , AMZN , DHR , COP , CSGP ,

Catalent closed Monday up ~20% on Monday following a report over the weekend that Danaher (DHR) was interested in acquiring the contract manufacturer.

The Club shares how headlines involving Coterra Energy, Danaher and TJX impact its investment thesis.

Gainers Secoo Holding Limited (NASDAQ: SECO ) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ ) gained 41.5% to $3.54. SoundHound AI, Inc. (NASDAQ: SOUN ) shares climbed 39.7% to $3.9394. Shares of several AI related stocks traded higher amid continued momentum in AI related stocks. Shift Technologies, Inc. (NASDAQ: SFT ) surged 39% to $0.3800. Kalera Public Limited Company (NASDAQ: KAL ) shares climbed 34.1% to $9.05. Omeros Corporation (NASDAQ: OMER ) jumped 32% to $4.10 after the company announced it received a $200 million milestone payment from Rayner Surgical. Iveda Solutions, Inc. (NASDAQ: IVDA ) jumped 30% to $1.59. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO ) surged 29% to $1.5262. SenesTech, Inc. (NASDAQ: SNES ) gained 26.2% to $5.30 as the company said ContraPest was approved for general use in New York. Catalent, Inc. (NYSE: CTLT ) shares gained 23.6% to $69.39 following a media report stating Danaher is interested in acquiring Catalent. Quantum Computing, Inc. (NASDAQ: QUBT ) jumped 23% to $3.03.

Catalent stock launched higher Monday on a rumor that Danaher could acquire it in a bid to compete with Thermo Fisher Scientific.

Catalent, Inc. (CTLT) surged on Monday after Bloomberg reported over the weekend that Danaher (DHR) had shown takeover interest in the contract manufacturer. Read the full story here.

Danaher Corporation (NYSE: DHR ) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT ). According to the sources, the recent moves by the life science firm valued Catalent at a significant premium. It''s unclear how Catalent will proceed or whether it''s receptive to a takeover offer, Bloomberg reported citing people familiar with the matter. Related: Danaher Says … Full story available on Benzinga.com

Life Sciences Company Danaher Corp. is interested in taking over contract manufacturer Catalent Inc. and is willing to pay a significant premium for the…

Gainers Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE ) shares surged 31.48% to $1.42 in pre-market trading. Arqit Quantum Inc. (NASDAQ: ARQQ ) shares rose 20.0% to $3 in pre-market trading. Catalent, Inc. (NYSE: CTLT ) rose 17.64% to $65.94 in pre-market trading after Danaher Corporation (NYSE: DHR ) hinted at a deal with the life sciences company. SoundHound AI, Inc. (NASDAQ: SOUN ) shares rose 17.02% to $3.3 in pre-market trading amid the popularity of AI on social media. Edgio, Inc. (NASDAQ: EGIO ) rose 16.46% to $1.91 in pre-market trading after the downtrend on Friday. BigBear.Ai, Inc. (NYSE: BBAI ) shares rose 13.48% to $5.89 in pre-market trading. AMC Entertainment Holdings, Inc. (NYSE: AMC ) shares rose 8.05% to $6.57 in pre-market trading. C3.Ai, Inc. … Full story available on Benzinga.com

In this article, we take a look at the 5 safe stocks to buy according to hedge funds. If you want to read our detailed analysis of safe stocks, go directly to see the 12 Safe Stocks to Buy According to Hedge Funds. 5. Danaher Corporation (NYSE:DHR) Beta Value: 0.82 Number of Hedge Fund Holders: 89 […]

Life sciences company Danaher Corporation (DHR) has expressed interest in buying the contract manufacturer Catalent (CTLT), people familiar with the matter said. Read the full story here.

Medical equipment maker Danaher Corp has expressed interest in taking over contract drugmaker Catalent Inc , Bloomberg News reported on Saturday, citing people familiar with the matter.

Related Stocks: G , DHR , ADI , ACI , AGR ,

Related Stocks: DHR , AVGOP.PFD , CHRD , ACWX , AVGO ,

Danaher Corporation found using ticker (DHR) have now 20 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 326 and 270 calculating the mean target price we have 302.8. Given that the stocks previous close was at 265.98 this is indicating there is a potential upside of 13.8%. The 50 day MA is 266.03 and the 200 day moving average is 265. The market capitalisation for the company is $191,361m. Company Website: https://www.danaher.com [stock_market_widget type="chart" template="basic" color="green" assets="DHR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $217,851m based on the market concensus. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Related Stocks: GOVT , SHY , BNDW , AMT , DHR ,

On the surface, it may seem as if now’s not the time to buy industrial stocks. With macro issues still unresolved, and the threat of a 2023 global recession still looming, there is a lot of uncertainty surrounding the near-term operational performance of companies in the industrial sector. However, that uncertainty is not a reason to sit on the sidelines. For starters, for some stocks, high uncertainty equals favorable opportunity. That is, there are plenty of cyclical industrials still trading at heavily discounted valuations, as their prospects remain murky. Some stocks in this category have become overly discounted, creating a favorable risk/reward proposition. In other cases, there are industrial names currently benefiting from more positive trends. For example, companies with exposure to recent geopolitical conflicts, as well as companies with exposure to secular growth trends. Between these two categories, there are plenty of industrial stocks worth buying in today’s market, including these seven.

Currently, Danaher Corporation’s (DHR) stock is trading at $263.64, marking a fall of -0.84% from last night’s close. At this price, the stock is -13.22% below its 52-week high of $303.82 and 12.81% above its 52-week low of $233.71. Based on the past 30-day period, the stock price is -5.68% below the high and +8.65% […]

Danaher''s earnings have had three great years on the back of COVID-related demand. Click here to see our take on DHR stock.

Danaher is now down over 4% since announcing its latest earnings. Read more to know why I rate DHR stock as a sell.

https://www.investing.com/news/pro/danaher-pt-lowered-to-320-at-cowen-432SI-2987888

We attribute Tuesday''s 3% decline in DHR to management already preannouncing and shares making a large move into the print.

Danaher Corporation (NYSE: DHR), a provider of industrial and medical products, reported higher sales and net profit for the fourth quarter of 2022. Fourth quarter net income was $2.21 billion, or $2.99 per share, compared to $1.75 billion or $2.39 per share in the same period of last year. Adjusted earnings increased 7% year-over-year to $2.87 per […]

Danaher (DHR), which reported slowing topline growth in its Q4 2022 financial results earlier Tuesday, is impacting other life sciences tools and services providers.

Danaher Corporation (NYSE:NYSE:DHR) Q4 2022 Results Conference Call January 24, 2023 8:00 AM ETCompany Participants John Bedford - Vice President-Investor RelationsRainer Blair - President…

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Danaher Corp (NYSE: DHR) has logged Q4 FY22 adjusted EPS of $2.87 , up 6.5% Y/Y, surpassing the estimate of $2.51. Sales increased 2.5% to $8.36 billion, with 7.5% non-GAAP core and 7.5% non-GAAP base business core revenue growth, beating the $7.88 billion estimate. Revenues for FY22 increased 7.0% to $31.5 billion. Non-GAAP core revenue growth was 9.5%. Operating cash flow for FY22 reached … Full story available on Benzinga.com

Despite reporting better than expected Q4 2022 financials, Danaher Corporation (DHR) indicated a slowdown in topline growth Tuesday as the pandemic impact waned. Read the full story here.

WASHINGTON (dpa-AFX) - Danaher Corp. (DHR) reported a profit for its fourth quarter that increased from the same period last year and beat the Street estimates.The company''s bottom line totaled $2…

https://www.investing.com/news/stock-market-news/danaher-earnings-beat-by-037-revenue-topped-estimates-2986628

Danaher press release (DHR): Q4 Non-GAAP EPS of $2.87 beats by $0.32.Revenue of $8.37B (+2.8% Y/Y) beats by $430M.For the first quarter 2023, the Company anticipates that non-GAAP…